The “Star Trek” captain, a vice-president of Blue Origin, a Planet Labs’ co-founder, and a medical research platform’s co-founder all set to rocket to space on a Blue Origin flight on 12th October.
The 90-year-old Canadian actor William Shatner, best known for his character in Star Trek as Captain James T. Kirk is all set to fly with his crew. Star Crek premiered in the year 1966, has decided to fly with the real final frontier along with Blue Origin’s approaching crewed spaceflight. This will be the second team to fly with spaceflight for Blue Origin after the inaugural team flight.
This is the second-ever teamed spaceflight for Blue Origin after the inaugural teamed flight launched Jeff Bezos, the founder, and 3 other celebrities on a 10-minute journey to space and return on July 20, will be streamed live on the site BlueOrigin.com, beginning 90 minutes prior launch.
Lift-off is at present expected at 8:30 am (13:30 GMT or 9:30 a.m. EDT) from West Texas, Launch Site One. It said that the Federal Aviation Administration (FAA) could launch a review concerning the safety of Blue Origin and also cultural practices right after criticisms rose in media reports some days ago.
Why did William choose these people?
Among the crew members, Audrey Powers is the vice president of flight and mission operations of Blue Origin and has been with the company for 8 years. She takes care of all New Shepard flight operations, infrastructure for launch, vehicle maintenance, landing, and ground support, as said in her Blue Origin biography.
Another crewman, Chris Boshuizen is associated with Planet Labs (co-founder) in 2010 and worked as the company’s chief technology officer for five years. Planet has to date launched more than 450 satellites to perform the Earth’s mapping from space. Between 2008 and 2012, Boshuizen was a space mission architect at NASA’s Ames Research Center, where he co-invented the orbital satellite custom-made from a smartphone, known as the NASA Phonesat.
Glen de Vries, a co-founder of Medidata Solutions that creates software, which was used for quite 25,000 clinical trials for items starting from vaccines to a rare disease. De Vries is also vice-chair of healthcare and life sciences at Dassault Systèmes that acquired Medidata in 2019, and a trustee of Carnegie Mellon University. He is a private pilot.